VisiPlate is a pioneering brand in the field of ophthalmology, dedicated to revolutionizing the treatment of glaucoma. Their flagship product, VisiPlate, is a cutting-edge aqueous shunt that aims to provide a breakthrough solution for glaucoma patients. Remarkably thin, measuring 20 times thinner than a human hair, VisiPlate leverages nanotechnology to achieve unprecedented strength and flexibility.

This composition, made of alumina and Parylene-c, non-fibrotic materials, holds the potential to reduce the risk of scarring and blockage. One of the remarkable features of VisiPlate is its unique multichannel design, which creates outflow redundancy. This innovation may result in sustained intraocular pressure control over time.

Although VisiPlate is currently an investigational device and not available for use or sale in the United States, the brand's website provides a preview of the anticipated benefits it offers to glaucoma patients. Avisi Technologies, the company behind VisiPlate, is based in Redwood City, CA, and remains committed to advancing ophthalmic treatments for improved patient outcomes